MUSTANG BIO, INC. — Director's Dealing 2018

Dec 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2018-11-20

Reporting Person: Litchman Manuel MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-20	Common Stock	P	2500	$3.8881	Acquired	2500	Direct
2018-11-21	Common Stock	P	5000	$4.2096	Acquired	7500	Direct
2018-11-26	Common Stock	P	5000	$3.8707	Acquired	12500	Direct
2018-12-04	Common Stock	P	7500	$3.60	Acquired	20000	Direct
2018-12-10	Common Stock	P	8000	$3.3506	Acquired	28000	Direct

Footnotes

F1: Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 20, 2018 was $3.8751 to $3.8951, the range of prices for the purchase transactions on November 21, 2018 was $4.1992 to $4.219, the range of prices for the purchase transactions on November 26, 2018 was $3.8696 to $3.8708 and the range of prices for the purchase transactions on December 10, 2018 was $ 3.34 to $ 3.3532. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.